SynOx Therapeutics

About:

SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors.

Website: https://synoxtherapeutics.com

Twitter/X: SynOx_Tx

Top Investors: Hercules Capital, Medicxi, HealthCap, Bioqube Ventures, Forbion Capital Partners

Description:

SynOx Therapeutics focuses on developing emactuzumab, a monoclonal antibody targeting CSF-1R, for diffuse tenosynovial giant cell tumors and other conditions. The company is supported by experienced investors with a history in biopharma development.